Trial
NCT06348147
Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
—
Condition
Newly Diagnosed Multiple Myeloma
Intervention
Daratumumab
Why stopped
budget
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-09